Clinical

Dataset Information

RSHF in Colorectal Cancer


ABSTRACT: The purpose of this study is to study stereotactic radiotherapy with a dose of 40 Gy in 4 fractions over 2 weeks with concomitant 40 mg/m2 of irinotecan (1st and 3rd irradiation session).

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2096487 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR